113 related articles for article (PubMed ID: 38750985)
1. Mechanistic Insights into Yifei Sanjie Pill's Regulation of EMT to Enhance Gefitinib Treatment effect in NSCLC by in silico analysis and experimental validation.
Zhou R; Qin B; Zhuang Z; Li J; Tiangi Gao YS; Wu D; Yuan Y; Tang Y; Lin L
J Ethnopharmacol; 2024 May; ():118343. PubMed ID: 38750985
[TBL] [Abstract][Full Text] [Related]
2. Reduction in gefitinib resistance mediated by Yi-Fei San-Jie pill in non-small cell lung cancer through regulation of tyrosine metabolism, cell cycle, and the MET/EGFR signaling pathway.
Yang CZ; Guo W; Wang YF; Hu LH; Wang J; Luo JM; Yao XH; Liu S; Tao LT; Sun LL; Lin LZ
J Ethnopharmacol; 2023 Oct; 314():116566. PubMed ID: 37169317
[TBL] [Abstract][Full Text] [Related]
3. Deciphering the Effects and Mechanisms of Yi-Fei-San-Jie-pill on Non-Small Cell Lung Cancer With Integrating Network Target Analysis and Experimental Validation.
Yang H; Guo Q; Wu J; Zhong L; Sun L; Liu W; Wang J; Lin L
Front Pharmacol; 2022; 13():851554. PubMed ID: 35645820
[TBL] [Abstract][Full Text] [Related]
4. Yifei Sanjie formula alleviates lung cancer progression via regulating PRMT6-YBX1-CDC25A axis.
Tang J; Yin C; Chen M; Dong M; Xu Y
Environ Toxicol; 2024 May; 39(5):3225-3237. PubMed ID: 38357781
[TBL] [Abstract][Full Text] [Related]
5. [Mechanism of n-butanol fraction of Wenxia Formula combining with gefitinib in treating non-small cell lung cancer based on network pharmacology and in vitro experiment].
Chen RJ; Bi QY; Shi JM; Zhong J; Han JT; Ji XM
Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(2):471-486. PubMed ID: 38403323
[TBL] [Abstract][Full Text] [Related]
6. Pedunculoside inhibits epithelial-mesenchymal transition and overcomes Gefitinib-resistant non-small cell lung cancer through regulating MAPK and Nrf2 pathways.
Fan Q; Liang X; Xu Z; Li S; Han S; Xiao Y; Xu Q; Yuan R; Yang S; Gao H
Phytomedicine; 2023 Jul; 116():154884. PubMed ID: 37209605
[TBL] [Abstract][Full Text] [Related]
7. Deciphering the Molecular Mechanism of Yifei-Sanjie Pill in Cancer-Related Fatigue.
Wu Y; Zhou S; Pi D; Dong Y; Wang W; Ye H; Yi Z; Chen Y; Lin L; Ouyang M
J Oncol; 2023; 2023():5486017. PubMed ID: 36814560
[TBL] [Abstract][Full Text] [Related]
8. Systems biology strategy and experimental validation to uncover the pharmacological mechanism of Xihuang Pill in treating non-small cell lung cancer.
Zhuang Z; Huang D; Sheng ZR; Ye ZJ; Jiang H; Yuan Y; Qin B; Zhao Y; Pan HF; Tang Y
Phytomedicine; 2023 Jan; 108():154491. PubMed ID: 36368285
[TBL] [Abstract][Full Text] [Related]
9. Sensitization of Non-Small Cell Lung Cancer Cells to Gefitinib and Reversal of Epithelial-Mesenchymal Transition by Aloe-Emodin
Peng M; Zheng Z; Chen S; Fang L; Feng R; Zhang L; Tang Q; Liu X
Front Oncol; 2022; 12():908031. PubMed ID: 35677158
[TBL] [Abstract][Full Text] [Related]
10.
Wu Y; Pi D; Chen Y; Zuo Q; Lin L; Ouyang M
Evid Based Complement Alternat Med; 2022; 2022():2357616. PubMed ID: 36045663
[TBL] [Abstract][Full Text] [Related]
11. Network Pharmacology and Experimental Verification Strategies to Illustrate the Mechanism of Jian-Pi-Yi-Shen Formula in Suppressing Epithelial-Mesenchymal Transition.
Zhao Y; Li X; Wang F; Huang S; Du H; Li S; Chen J
Front Pharmacol; 2022; 13():873023. PubMed ID: 35656312
[TBL] [Abstract][Full Text] [Related]
12. Zoledronic acid re‑sensitises gefitinib‑resistant lung cancer cells by inhibiting the JAK/STAT3 signalling pathway and reversing epithelial‑mesenchymal transition.
Yang X; Gao Y; Liu Q; Wan L; Liu H; Bian W; Du Y; Huang C
Oncol Rep; 2021 Feb; 45(2):459-468. PubMed ID: 33416163
[TBL] [Abstract][Full Text] [Related]
13. Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation.
La Monica S; Madeddu D; Tiseo M; Vivo V; Galetti M; Cretella D; Bonelli M; Fumarola C; Cavazzoni A; Falco A; Gervasi A; Lagrasta CA; Naldi N; Barocelli E; Ardizzoni A; Quaini F; Petronini PG; Alfieri R
J Thorac Oncol; 2016 Jul; 11(7):1051-63. PubMed ID: 27006151
[TBL] [Abstract][Full Text] [Related]
14. Fucoxanthin extracted from Laminaria Japonica inhibits metastasis and enhances the sensitivity of lung cancer to Gefitinib.
Ming JX; Wang ZC; Huang Y; Ohishi H; Wu RJ; Shao Y; Wang H; Qin MY; Wu ZL; Li YY; Chang Zhou S; Chen H; Liu H; Xu R
J Ethnopharmacol; 2021 Jan; 265():113302. PubMed ID: 32860893
[TBL] [Abstract][Full Text] [Related]
15. Delivery of gefitinib in synergism with thymoquinone
Upadhyay P; Ghosh A; Basu A; Pranati PA; Gupta P; Das S; Sarker S; Bhattacharjee M; Bhattacharya S; Ghosh S; Chattopadhyay S; Adhikary A
Biomater Sci; 2021 Dec; 9(24):8285-8312. PubMed ID: 34766965
[TBL] [Abstract][Full Text] [Related]
16. Xie-Bai-San increases NSCLC cells sensitivity to gefitinib by inhibiting Beclin-1 mediated autophagosome formation.
Ma C; Zhang X; Mo X; Yu Y; Xiao Z; Wu J; Ding L; Lei C; Zhu Y; Zhang H
Phytomedicine; 2024 Mar; 125():155351. PubMed ID: 38232540
[TBL] [Abstract][Full Text] [Related]
17. Astragalus mongholicus Bunge and Curcuma aromatica Salisb. inhibits liver metastasis of colon cancer by regulating EMT via the CXCL8/CXCR2 axis and PI3K/AKT/mTOR signaling pathway.
Liu F; Liang Y; Sun R; Yang W; Liang Z; Gu J; Zhao F; Tang D
Chin Med; 2022 Aug; 17(1):91. PubMed ID: 35922850
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal positive regulation between Cx26 and PI3K/Akt pathway confers acquired gefitinib resistance in NSCLC cells via GJIC-independent induction of EMT.
Yang J; Qin G; Luo M; Chen J; Zhang Q; Li L; Pan L; Qin S
Cell Death Dis; 2015 Jul; 6(7):e1829. PubMed ID: 26203858
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3.
Yue J; Lv D; Wang C; Li L; Zhao Q; Chen H; Xu L
Oncogene; 2018 Aug; 37(31):4300-4312. PubMed ID: 29717264
[TBL] [Abstract][Full Text] [Related]
20. [
Wu Y; Zuo Q; Luo W; Wang H; Pi D; Chen Q; Chen L; Lin L; Ouyang M
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Nov; 43(11):1839-1849. PubMed ID: 38081600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
